| scholarly article | Q13442814 |
| P50 | author | Karsten Becker | Q39501983 |
| Barbara C. Kahl | Q41674855 | ||
| Alessandra Bragonzi | Q43269735 | ||
| Nicola Ivan Lorè | Q57630158 | ||
| Georg Peters | Q64010237 | ||
| P2093 | author name string | Richard A Proctor | |
| Andre Kriegeskorte | |||
| Camilla Riva | |||
| Marco Kelkenberg | |||
| P2860 | cites work | OpenCFU, a new free and open-source software to count cell colonies and other circular objects | Q21090811 |
| Staphylococcus aureus infections | Q28131787 | ||
| Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response | Q30394473 | ||
| Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis | Q33213284 | ||
| Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. | Q34026284 | ||
| Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. | Q34232085 | ||
| sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. | Q34319176 | ||
| Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. | Q34978780 | ||
| Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease | Q35690337 | ||
| Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection | Q36090341 | ||
| Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections | Q36422855 | ||
| Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease | Q36957900 | ||
| Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection | Q37058032 | ||
| Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis | Q37215494 | ||
| Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis | Q37463364 | ||
| Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection | Q37719880 | ||
| Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy | Q37819539 | ||
| The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates | Q38898519 | ||
| Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation | Q39732905 | ||
| Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus | Q40030687 | ||
| Growth characteristics of group A streptococci in a new chemically defined medium | Q41155677 | ||
| In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus | Q41911383 | ||
| Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. | Q42204317 | ||
| Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles | Q42587250 | ||
| Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle | Q42845429 | ||
| Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia | Q42948319 | ||
| Molecular epidemiology and antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus blood culture isolates: results of the Quebec Provincial Surveillance Programme | Q43942393 | ||
| Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial | Q45247343 | ||
| Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients | Q48689549 | ||
| Treatment of Skin and Soft Tissue Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus in Europe: The Role of Trimethoprim-sulfamethoxazole | Q57849011 | ||
| Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection | Q61477464 | ||
| Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence | Q61477540 | ||
| Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis | Q61477562 | ||
| Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis | Q74422423 | ||
| National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients | Q79886453 | ||
| Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus | Q80107472 | ||
| Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008 | Q84402006 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 7265-7272 | |
| P577 | publication date | 2015-09-14 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge | |
| P478 | volume | 59 |
| Q28396297 | A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway |
| Q40170178 | An aroD Ochre Mutation Results in a Staphylococcus aureus Small Colony Variant That Can Undergo Phenotypic Switching via Two Alternative Mechanisms |
| Q36675223 | Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections. |
| Q92648818 | Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus |
| Q64276230 | In Vitro Activity of the Bacteriophage Endolysin HY-133 against Small-Colony Variants and Their Corresponding Wild Types |
| Q48325433 | Influence of IS256 on Genome Variability and Formation of Small-Colony Variants in Staphylococcus aureus |
| Q92534398 | MpsAB is important for Staphylococcus aureus virulence and growth at atmospheric CO2 levels |
| Q92494196 | Phenotypic Stability of Staphylococcus Aureus Small Colony Variants (SCV) Isolates from Cystic Fibrosis (CF) Patients |
| Q91285393 | Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study |
Search more.